MySTYL'One
Jan. 12, 2023
In this paper you will find a study showing that surface characteristics and preprocessing can prevail over the impact of polymorphism on manufacturability for oral solid dosage forms. The paper is available in the PAPERS section.
Find others papers here and learn about
In this paper you will find a study showing that surface characteristics and preprocessing can prevail over the impact of polymorphism on manufacturability for oral solid dosage forms. The paper is available in the PAPERS section.
Find others papers here and learn about
#mannitol #roller compaction #direct compression #polymorphism #powder characterization #tabletability
MySTYL'One
Dec. 20, 2022
In this paper you will find a study that investigates on Hydrochlorothiazide/Losartan Potassium used to prepare compound tablets through the investigation of the compression and mechanical properties of mixed powders to determine the formulation and preparation factors. The paper is available in the PAPERS section.
Find others papers here and learn about
In this paper you will find a study that investigates on Hydrochlorothiazide/Losartan Potassium used to prepare compound tablets through the investigation of the compression and mechanical properties of mixed powders to determine the formulation and preparation factors. The paper is available in the PAPERS section.
Find others papers here and learn about
#STYL'One #mechanical properties #direct compression #dissolution rate #bioavailibility #compression properties
MySTYL'One
Dec. 19, 2022
Get access for this online event replay.
Date: Friday, January 27th, 2022
Time: 11am EST/4PM GMT/8am PST
Duration: 60 minutes
"Dosage Form Design & Patient Compliance: Exploring ODTs as a Patient-centric Solution" - by David Elder, Principal Consultanl - David P Elder Consultancy, and Ralph Gosden, Head of Zydis Product Development - Catalent.
Thermofisher Scientific
Nov. 23, 2022
With the ever-growing pressure to get new therapies to patients faster, predictive modeling and simulation tools are increasingly recognized as critical enabling technologies for accelerating drug product development. In the development of oral solid dosage forms, predictive modeling and simulation tools of the manufacturing processes can enhance process understanding, save on API supply, improve product quality, and reduce or eliminate many of the bottlenecks associated with empirical method...
With the ever-growing pressure to get new therapies to patients faster, predictive modeling and simulation tools are increasingly recognized as critical enabling technologies for accelerating drug product development. In the development of oral solid dosage forms, predictive modeling and simulation tools of the manufacturing processes can enhance process understanding, save on API supply, improve product quality, and reduce or eliminate many of the bottlenecks associated with empirical methods.
Each active pharmaceutical ingredient (API) has its own set of unique physical and chemical properties that can affect the success of product formulations and manufacturing routes. On account of this, the manufacturing process for solid dosage forms need to be thoroughly understood. Determining robust formulations and processes for a given compound requires a deep understanding of material science and powder behavior.
#R&D #STYL'One evo #Powder compaction #science lab #Material science
Adare Pharma Solutions
Oct. 20, 2022
Taste masking, combined with swallowability and palatability, are integral considerations for oral drug formulations; ensuring both as part of a drug product’s final formulation can serve to increase patient acceptability and adherence to the therapy, which in turn can bolster regulatory acceptance and commercial potential.
Adare Pharma Solutions
Oct. 6, 2022
To address the challenges of pediatric formulations, specialized technology platforms are often needed to provide ease of application and improve patient outcomes.
MySTYL'One
July 26, 2022
Replay of the webinar
--> MySTYL'One members: access the webinar page for the full replay
--> Not a member, but would like to view the video? Fill out online request form: https://form.jotform.com/222024289539055
Access the replay of the webinar "Fundamental Investigations on Bilayer tablets - Effects of Process Parameters and Geometry on Interfacial Strength" with thanks to the links above.
Speakers:
*Jan Finke, Division Head Pharma & Bioparticle Technology, iPAT, TU Braunschweig &am...
Replay of the webinar
--> MySTYL'One members: access the webinar page for the full replay
--> Not a member, but would like to view the video? Fill out online request form: https://form.jotform.com/222024289539055
Access the replay of the webinar "Fundamental Investigations on Bilayer tablets - Effects of Process Parameters and Geometry on Interfacial Strength" with thanks to the links above.
Speakers:
*Jan Finke, Division Head Pharma & Bioparticle Technology, iPAT, TU Braunschweig & Senior Scientist, Fraunhofer IST
*Bruno Leclercq, Science Lab Head and Business Development Manager, MEDELPHARM
Webinar agenda:
Why should you watch?
pharmaceutical-technology
July 25, 2022
On this article you will find how pharmaceutical companies can improve the efficiency of their entire product development and drug commercialisation process with the ever-rising costs of bringing a drug to market. A well-known source of bottlenecks, delays, and technical setbacks is process scale-up, where production moves from the laboratory to full-scale GMP manufacturing
MySTYL'One
Sept. 8, 2022
Access the transcript of the webinar "Fundamental Investigations on Bilayer tablets - Effects of Process Parameters and Geometry on Interfacial Strength"
Speakers:
*Jan Finke, Division Head Pharma & Bioparticle Technology, iPAT, TU Braunschweig & Senior Scientist, Fraunhofer IST
*Bruno Leclercq, Science Lab Head and Business Development Manager, MEDELPHARM
Webinar agenda:
Access the transcript of the webinar "Fundamental Investigations on Bilayer tablets - Effects of Process Parameters and Geometry on Interfacial Strength"
Speakers:
*Jan Finke, Division Head Pharma & Bioparticle Technology, iPAT, TU Braunschweig & Senior Scientist, Fraunhofer IST
*Bruno Leclercq, Science Lab Head and Business Development Manager, MEDELPHARM
Webinar agenda:
MySTYL'One
July 22, 2022
The present works demonstrated from a study to predict capping on biconvex tablets from a wide range of products (18 formulations, 8 of which presenting capping), using the properties characterized on defect-free flat-faced tablets (tensile strength, solid fraction, elastic recovery, etc.). The study is available in the PAPERS section.
Find others papers here and learn about